SYK · NYSE · CIK 0000310764
Stryker Corporation
No equity stake in another company appears in Stryker Corporation's filings. That is the sourced answer, not a hole in the research.
Stryker Corporation - Profile
- Sector
- Health CareGICS
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
- Listed on
- NYSE
- Employees
- 22,000stated 2012
- Incorporated in
- Michigan
- Financial year ends
- 31 December
Source
Address, industry classification, listing and incorporation come from Stryker Corporation's own SEC filer record, so the industry is the SEC's dry classification rather than a marketing label. The website comes from Wikidata. The headcount is the figure Wikidata carries for 2012, not a figure this site has verified against a filing. The description is the opening paragraph of its Wikipedia article, used under CC BY-SA 4.0.
Share price
SYK
Description
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Who owns Stryker Corporation.
sized by
modelled, reported or pending
Select a row or a slice for its provenance: the filing it came from, when it was measured, and the arithmetic behind it if it was modelled.
The full register, from 13F filings
The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 2,267 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.
2,267 managers reported a position, together holding 299.1m shares, or 78.0% of the company. The 40 largest are listed. Percentages are of the 383.4m shares outstanding at 31 Mar 2026, the count in force when this quarter was measured rather than the count today.
Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.
What a reader needs to know to read these numbers
- Stryker does not file Form 13F. Its complete EDGAR filing history (submissions JSON for CIK 0000310764, checked 17 August 2026) contains no 13F-HR or 13F-NT of any vintage, consistent with it not acting as an institutional investment manager.
- The holdings list is empty and that is the sourced finding, not a gap. The FY2025 Form 10-K (period ended 31 December 2025, filed 11 February 2026) and the Q2 FY2026 Form 10-Q (period ended 30 June 2026, filed 31 July 2026) were both fetched and searched in full for 'equity method', 'equity investment', 'non-marketable', 'measurement alternative', 'unrealized', 'joint venture', 'strategic investment', 'venture', 'investee', 'ownership interest', 'collaboration agreement', 'minority interest' and 'corporate venture capital': none appear. The only equity-adjacent language found is (a) mutual funds and debt securities inside a deferred-compensation marketable-securities portfolio, (b) a pension-plan asset-allocation target of 26-32 percent 'equity securities' inside the pension footnote, which is a plan-trust allocation category, not a Stryker-owned stake in a named company, and (c) a single unquantified mention of 'other investments' inside the generic financial-instruments list in the accounting-policy note, with no dollar figure or counterparty attached. Stryker grows through outright, wholly owned acquisitions, most recently Inari Medical (closed 2025), rather than minority stakes.
- Stryker has a single class of common stock, $0.10 par value, one vote per share (10-Q cover page, 30 June 2026). There is no dual-class structure.
- The Stryker family story: Ronda E. Stryker, a director since 1984 and granddaughter of founder Dr. Homer Stryker, beneficially owns 15,355,273 shares (4.0 percent) per the 2026 proxy's own beneficial-ownership table. Unlike Broadcom's or Walmart's outside-the-group family-vehicle pattern, her holding sits directly INSIDE the 'Executive officers and directors as a group (21 persons)' row (17,778,869 shares, 4.6 percent), because she is a sitting director captured in that same table. The proxy's footnote 6 flags that 13,120,495 of her 15,351,668 owned shares carry only shared, not sole, voting and dispositive power, the closest hint at a family trust or foundation structure, but the proxy neither names a separate vehicle nor gives it its own row, so no additional family holding outside the officers group could be sourced.
- John W. Brown, Stryker's Chairman and CEO from 1977 to 2003, is the third-largest disclosed holder (20,056,245 shares, 5.2 percent) via a 2021 Schedule 13G/A. He is not part of the Stryker founding family and is not a current officer or director, so his row is separate from, and does not roll into, the officers and directors group.
- Vanguard and BlackRock disagreement, recorded rather than resolved. The register uses each manager's own most recent Form 13F-HR: Vanguard 33,907,291 shares as of 31 December 2025 (Vanguard filed Form 13F-NT, a notice rather than a holdings report, for the quarters ended 31 March 2026 and 30 June 2026 under CIK 0000102909); BlackRock 27,414,742 shares as of 30 June 2026. Stryker's 2026 proxy reports smaller, older figures for both, sourced to Schedule 13G/A filings from early 2024 covering ownership as of late 2023: Vanguard 31,149,173 shares (8.1 percent) as of 29 December 2023, and BlackRock 24,924,572 shares (6.5 percent) as of 31 December 2023.
- Percentages for the 13F rows are computed by this research against 383,573,046 shares outstanding on 30 June 2026 (10-Q cover page), except the Vanguard row, which uses 382,688,675 shares outstanding on 31 January 2026 (FY2025 10-K cover page), the closest available count to Vanguard's 31 December 2025 reporting date.
- The proxy's own beneficial-ownership percentages (Ronda E. Stryker's 4.0 percent, the officers-and-directors group's 4.6 percent, and John W. Brown's 5.2 percent) are taken as filed rather than recomputed; the proxy states they assume continued ownership as of 28 February 2026 against the 9 March 2026 record-date share count of 382,984,253.
- Market capitalisation of $130.11 billion is the rounded figure published on the source page as of 14 August 2026. It is not used as the basis for any percentage calculation in this file.
Looked for, not found
Recorded rather than filled in. Each of these is a place where a number could have been invented and was not.
- Whether any family trust, foundation, or LLC vehicle holds Stryker shares on behalf of the broader Stryker family (descendants of founder Dr. Homer Stryker) outside Ronda E. Stryker's own beneficial-ownership row. The 2026 proxy's 5-percent-owner table lists only Vanguard, BlackRock, and John W. Brown; no family vehicle crosses the Schedule 13D/G 5 percent disclosure threshold, and an independent EDGAR full-text search for Stryker-family-linked 13D/G filers was not completed within the time budget.
- John W. Brown's current holding. His 20,056,245-share, 5.2 percent figure is sourced only to a Schedule 13G/A filed 9 February 2021 reporting data as of 31 December 2020; no more recent 13G/A or 13D for him was located on EDGAR, so his present-day position is unconfirmed.
- The identity, size, and counterparty of 'other investments' mentioned once in the FY2025 10-K's financial-instruments accounting-policy note. No dollar figure or breakdown accompanies the phrase anywhere in the 10-K or the Q2 FY2026 10-Q.
- Any equity position Stryker may have taken during its fiscal Q3 2026. The Q3 FY2026 10-Q (quarter ending on or about 30 September 2026) was not yet filed as of 17 August 2026, per the EDGAR submissions feed for CIK 0000310764.
- 13F positions for other large active managers (e.g. Capital Group, T. Rowe Price, State Street's smaller peers) beyond the seven named in the research brief were not checked; the register is limited to the requested seven managers plus the proxy layer.